Droid, my dreaded ctic passed phase 2, phase 3 looked "good," like this one, anticipation built, and it was all FDA voters with a thumbs down. If Multikine fails I will be 0 for 2.
You’re right, however, IMO, it only matters to a small degree—any impact to pps will be temporary. PIII results will be the deciding factor, regardless of what between now and then.
I don’t believe a lower pps at the time results are announced will have much (if any) impact on the pps following the announcement of a successful PIII.
Market Data 
Markets 
AI
